Héron J F
Rev Prat. 1989 Nov 11;39(26):2325-8.
Adjuvant therapy remains necessary for all ovarian cancers expanding outside the ovary, and should be adjusted to stage and persistent tumor burden. Many problems need precise answers. Although progresses have been made, results are still unsatisfactory. The need for multicentric studies and trials is utmost underlined.
对于所有扩散至卵巢外的卵巢癌,辅助治疗仍然是必要的,并且应根据分期和持续的肿瘤负荷进行调整。许多问题需要精确的答案。尽管已取得进展,但结果仍不尽人意。多中心研究和试验的必要性被着重强调。